Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

As mpox cases rise again in parts of Central Africa, the Democratic Republic of the Congo is pioneering an integrated public health response for HIV ...

Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...

Liyab Aguingay Treatment Hub in Sorsogon addresses the healthcare needs of individuals with HIV in the Province of Sorsogon.

The HIV-positive partner should schedule routine checkups with their doctor for regular testing of their CD4 count (a type of blood cell that’s impacted by HIV) and viral load (the amount of the ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Another gamechanger which helped Thailand progress towards ending AIDS is generic manufacturing of lifesaving antiretroviral ...

In his budget speech in May, the finance minister, Enoch Godongwana, stated that no new allocations are being made to deal ...

With tickets starting at $25,000, the amfAR charity dinner has been bringing stars to Cap d'Antibes, Cannes' quieter, palm-lined neighbour, since 1993 in the name of HIV/AIDS research.

Higher rates of cancers associated with immunosuppression in ethnically minoritized men living with HIV highlight gaps in HIV diagnosis and treatment.

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Among patients starting therapy with CD4 counts < 50 cells/mm 3, each 50-cells/mm 3 increment in CD4 count at 6 months was associated with a lower risk for death or AIDS: Those with a rise of 0 to ...